Literature DB >> 27121983

A reduction of prothrombin conversion by cardiac surgery with cardiopulmonary bypass shifts the haemostatic balance towards bleeding.

Romy M W Kremers1, Yvonne P J Bosch, Saartje Bloemen, Bas de Laat, Patrick W Weerwind, Bas Mochtar, Jos G Maessen, Rob J Wagenvoord, Raed Al Dieri, H Coenraad Hemker.   

Abstract

Cardiac surgery with cardiopulmonary bypass (CPB) is associated with blood loss and post-surgery thrombotic complications. The process of thrombin generation is disturbed during surgery with CPB because of haemodilution, coagulation factor consumption and heparin administration. We aimed to investigate the changes in thrombin generation during cardiac surgery and its underlying pro- and anticoagulant processes, and to explore the clinical consequences of these changes using in silico experimentation. Plasma was obtained from 29 patients undergoing surgery with CPB before heparinisation, after heparinisation, after haemodilution, and after protamine administration. Thrombin generation was measured and prothrombin conversion and thrombin inactivation were quantified. In silico experimentation was used to investigate the reaction of patients to the administration of procoagulant factors and/or anticoagulant factors. Surgery with CPB causes significant coagulation factor consumption and a reduction of thrombin generation. The total amount of prothrombin converted and the rate of prothrombin conversion decreased during surgery. As the surgery progressed, the relative contribution of α2-macroglobulin-dependent thrombin inhibition increased, at the expense of antithrombin-dependent inhibition. In silico restoration of post-surgical prothrombin conversion to pre-surgical levels increased thrombin generation excessively, whereas co-administration of antithrombin resulted in the normalisation of post-surgical thrombin generation. Thrombin generation is reduced during surgery with cardiopulmonary bypass because of a balance shift between prothrombin conversion and thrombin inactivation. According to in silico predictions of thrombin generation, this new balance increases the risk of thrombotic complications with prothrombin complex concentrate administration, but not if antithrombin is co-administered.

Entities:  

Keywords:  Cardiopulmonary bypass; prothrombin conversion; thrombin generation; thrombin inactivation; transfusion

Mesh:

Substances:

Year:  2016        PMID: 27121983     DOI: 10.1160/TH16-02-0094

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

Review 1.  Thrombin generation and bleeding in cardiac surgery: a clinical narrative review.

Authors:  John Fitzgerald; Robert McMonnies; Aidan Sharkey; Peter L Gross; Keyvan Karkouti
Journal:  Can J Anaesth       Date:  2020-03-04       Impact factor: 5.063

2.  Functional changes in hemostasis during asexual and sexual parasitemia in a controlled human malaria infection.

Authors:  Shengshi Huang; Wouter van der Heijden; Isaie J Reuling; Jun Wan; Qiuting Yan; Romy M W de Laat-Kremers; Andre J Van der Ven; Philip G de Groot; Matthew McCall; Robert W Sauerwein; Teun Bousema; Mark Roest; Marisa Ninivaggi; Quirijn de Mast; Bas de Laat
Journal:  PLoS One       Date:  2022-07-15       Impact factor: 3.752

3.  Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin.

Authors:  Romy M W Kremers; Stéphane Zuily; Hilde Kelchtermans; Tessa C Peters; Saartje Bloemen; Véronique Regnault; H Coenraad Hemker; Philip G de Groot; Denis Wahl; Bas de Laat
Journal:  Blood Adv       Date:  2018-06-12

4.  Deciphering the coagulation profile through the dynamics of thrombin activity.

Authors:  Romy M W de Laat-Kremers; Qiuting Yan; Marisa Ninivaggi; Moniek de Maat; Bas de Laat
Journal:  Sci Rep       Date:  2020-07-27       Impact factor: 4.379

5.  Comparison of 4-Factor Prothrombin Complex Concentrate With Frozen Plasma for Management of Hemorrhage During and After Cardiac Surgery: A Randomized Pilot Trial.

Authors:  Keyvan Karkouti; Justyna Bartoszko; Deep Grewal; Cielo Bingley; Chantal Armali; Jo Carroll; Hans-Peter Hucke; Amie Kron; Stuart A McCluskey; Vivek Rao; Jeannie Callum
Journal:  JAMA Netw Open       Date:  2021-04-01

6.  Semi-automated thrombin dynamics applying the ST Genesia thrombin generation assay.

Authors:  Audrey Carlo; Qiuting Yan; Hugo Ten Cate; Romy De Laat-Kremers; Bas De Laat; Marisa Ninivaggi
Journal:  Front Cardiovasc Med       Date:  2022-07-26

7.  Assessing the individual roles of FII, FV, and FX activity in the thrombin generation process.

Authors:  Cuicui Bai; Joke Konings; Marisa Ninivaggi; Marcus Lancé; Bas de Laat; Romy de Laat-Kremers
Journal:  Front Cardiovasc Med       Date:  2022-09-20

8.  Tailoring the effect of antithrombin-targeting therapy in haemophilia A using in silico thrombin generation.

Authors:  Romy M W de Laat-Kremers; Marisa Ninivaggi; Iris van Moort; Moniek de Maat; Bas de Laat
Journal:  Sci Rep       Date:  2021-07-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.